Daewoong and Indonesia’s Ministry of Health Discuss Collaboration for Mutual Growth Aligned with Local Production of Medical Devices

Writer

Manager

May 11, 2025

Daewoong and Indonesia’s Ministry of Health Discuss Collaboration for Mutual Growth Aligned with Local Production of Medical Devices

· Discussed collaboration opportunities based on the seven pillars of health transformation, especiallyrelated with transformation of local production of medical device and medicine and strengthening internal human resources at the Ministry of Health

· CGBio is committed toestablishing local production of medical devices in Indonesia with the Minister's support for upcoming December

· Minister of Health Budi Gunadi Sadikin praised Daewoong’s efforts in fostering Indonesian youth into global talents through scholarships and technical support

(Jakarta, February 14^th 2025)

Daewoong, a leading globalpharmaceutical group based in South Korea, announced on February 14^ththat it had conducted an official visit alongside the Indonesian Minister ofHealth, Budi Gunadi Sadikin, to discuss the collaboration direction based on theMinistry’s seven pillars of health transformation as a key collaborativepartner.

Especially, the Minister ofHealth emphasized the increasing importance of domestic production ofpharmaceuticals and medical devices, particularly in relation to TKDN (DomesticComponent Level), and stressed the necessity of ensuring a robust domesticsupply chain for the health and safety of Indonesian citizens. “We areparticularly concerned about the urgent need for domestic production ofcritical medical devices. We hope that Daewoong will contribute to the localproduction of these medical devices in Indonesia,” the Minister added.

In response, Hyun Seung Yu,CEO of CGBIO, stated: “This collaboration marks a significant milestone inaligning CGBIO's global vision with Indonesia’s goal of achieving medicaldevice self-reliance. Through continued research collaborations with Indonesianuniversities and the establishment of a local manufacturing facility, we aim toposition Indonesia as a leading medical device hub in Asia.”

CGBIO, a specialized medicaldevice production affiliate of Daewoong Group, has reaffirmed its commitment toestablishing a medical device manufacturing plant in Indonesia. The companyplans to utilize local resources for production and technology transfer,further strengthening Indonesia’s position in the medical device industry.

Eric Aoh, Head of theBusiness Team at CGBIO, also stated, “CGBIO is not only committed to producingmedical products in Indonesia but also to enhancing the professionalism ofdoctors. That is why we continue to organize learning sessions for doctors,such as the VCP program and KOL conference.”

During the visit, MinisterBudi Gunadi Sadikin also expressed his deep appreciation for Daewoong’s effortsin nurturing Indonesian talent to Daewoong Biologics Indonesia (led by ShawnPark) and its subsidiary CGBIO (led by CEO Hyun Seung Yu). The Minister wasparticularly impressed by the development of young talents in Indonesia,through Daewoong's initiatives which have been cultivating their expertise andtransforming into global talents.

Since 2009, Daewoong hasbeen a steadfast supporter of global talent development, awarding scholarshipsto over 2,000 outstanding students at top Indonesian universities. In addition,Daewoong has supportedmore than 100 medical professionals and facilitated technology transfer tobolster research in healthcare. A key highlight of Daewoong’s ongoingcollaboration is its joint research with prominent Indonesian universities,such as UI, ITB, and IPB.

Minister Budi Gunadi Sadikinshared his experience: “When I visited Daewoong in 2021, I was deeply moved towitness Indonesian youth growing into global talents, thanks to Daewoong'scommitment to fostering their skills through scholarships and technical support.These efforts not only enhance the capabilities of Indonesian individuals butalso significantly contribute to improving the nation’s healthcare system andoverall quality of life.”

Baik In Hyun, Head ofDaewoong Biologics Indonesia’s business unit, expressed gratitude to theMinistry of Health: “We are thankful to the Ministry of Health of Indonesia, astrategic partner of Daewoong for over 20 years, for their unwavering supportin fostering shared growth and elevating the healthcare quality and well-beingof Indonesia. We remain fully committed to deepening our collaboration withIndonesia, empowering its top talents, and helping bring them to the globalstage.”

Additionally, Daewoong hasbeen a key player in Indonesia’s biopharmaceutical sector since the opening ofits Jakarta branch in 2005. In 2012, Daewoong established Daewoong Infion,Indonesia’s first biopharmaceutical production facility, which supportstechnology transfer for biopharmaceutical manufacturing and offersHalal-certified EPO and EGF medicines. Further solidifying its commitment tolocal production, Daewoong completed the construction of a state-of-the-artstem cell therapy facility in Indonesia in 2024. This 20-year journeyexemplifies Daewoong’s unwavering dedication to mutual growth and innovation inpartnership with Indonesia.

Finally, Minister BudiGunadi Sadikin underscored the need to strengthen the competencies of theMinistry of Health’s human resources, which aligns with the seventh pillar ofIndonesia’s health transformation. In light of this, Daewoong expressed itsconfidence in supporting the Ministry’s initiatives through variouscollaborations, such as the invitation program with Indonesian Ministry ofHealth’s Internal Transformation Office held last September, where Daewoongshared its growth-centered key human resource programs and interacted withyoung Indonesian talents working at Daewoong.

- # # # -

Ferry Maulana Prateja

Public Relations Supervisor

Daewoong Pharmaceutical Company Indonesia

+62 857 1839 7889

ferry.prateja@daewoong.co.kr

‍

list

Daewoong and Indonesia’s Ministry of Health Discuss Collaboration for Mutual Growth Aligned with Local Production of Medical Devices

· Discussed collaboration opportunities based on the seven pillars of health transformation, especiallyrelated with transformation of local production of medical device and medicine and strengthening internal human resources at the Ministry of Health

· CGBio is committed toestablishing local production of medical devices in Indonesia with the Minister's support for upcoming December

· Minister of Health Budi Gunadi Sadikin praised Daewoong’s efforts in fostering Indonesian youth into global talents through scholarships and technical support

‍

Privacy Policy

이용약관